The fate of renal allografts treated with OKT3 for steroid-resistant rejection.
Veronese
F V
FV
Renal Transplant Unit, Hospital de Clínicas de Porto Alegre, Brazil.
Gonçalves
L F
LF
Vilarinho
L L
LL
Macedo
V S
VS
Manfro
R C
RC
D000328:Adult; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012086:Reoperation; D013256:Steroids / Q000627:therapeutic use; D015996:Survival Rate; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids